Q2 2014 Holdings
Filed 2014-08-11 | 104 holdings | $405.8K | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2014-08-20) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Novartis AG(NVSN)A | SPONSORED ADR | 66987V109 | $48.3K | 533,100 | 11.9% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $24.9K | 430,000 | 6.1% |
| Teva Pharmaceutical Industries(TEVA) | ADR | 881624209 | $23.3K | 444,500 | 5.7% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $22.3K | 213,600 | 5.5% |
| Pfizer Inc(PFE) | COM | 717081103 | $19.4K | 654,596 | 4.8% |
| GlaxoSmithKline PLC | SPONSORED ADR | 37733W105 | $16.0K | 300,000 | 4.0% |
| Shire PLCA | SPONSORED ADR | 82481R106 | $14.1K | 180,000 | 3.5% |
| Sanofi(SNY)A | SPONSORED ADR | 80105N105 | $12.7K | 120,000 | 3.1% |
| Seattle Genetics Inc | COM | 812578102 | $11.4K | 297,800 | 2.8% |
| Redhill Biopharma Ltd | SPONSORED ADS | 757468103 | $9.2K | 1,546,880 | 0.0% |
| BioMarin Pharmaceutical Inc(BMRN)A | COM | 09061G101 | $7.5K | 120,000 | 1.8% |
| Biogen Idec Inc(BIIB)A | COM | 09062X103 | $6.9K | 22,000 | 1.7% |
| Allergan Inc ed States | COM | 18490102 | $6.8K | 40,000 | 1.7% |
| Verint Systems Inc(VTY) | COM | 92343X100 | $6.6K | 134,550 | 1.6% |
| Dyax Corp | COM | 26746E103 | $6.2K | 650,000 | 1.5% |
| Eli Lilly & Co(LLY) | COM | 532457108 | $6.2K | 100,000 | 1.5% |
| Avanir Pharmaceuticals Inc | CL A NEW | 05348P401 | $5.6K | 1,000,000 | 1.4% |
| Medivation Inc | COM | 58501N101 | $5.4K | 70,000 | 1.3% |
| Orbotech Ltd | ORD | M75253100 | $5.2K | 343,602 | 1.3% |
| Acorda Therapeutics Inc | COM | 00484M106 | $5.1K | 150,000 | 1.2% |
| Amgen Inc | COM | 31162100 | $4.7K | 40,000 | 1.2% |
| B Communications LtdA | SHS | M15629104 | $4.7K | 241,705 | 1.2% |
| Yum! Brands Inc(YUM) | COM | 988498101 | $4.6K | 56,433 | 1.1% |
| CSX Corp(CSX) | COM | 126408103 | $4.6K | 148,325 | 1.1% |
| Walgreen Co | COM | 931422109 | $4.5K | 60,993 | 1.1% |
| Pharmacyclics Inc | COM | 716933106 | $4.5K | 50,000 | 1.1% |
| Towers Watson & Co | CL A | 891894107 | $4.4K | 41,740 | 1.1% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $4.3K | 105,000 | 1.1% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $4.1K | 50,000 | 1.0% |
| Incyte Corp Ltd(INCY) | COM | 45337C102 | $4.1K | 73,000 | 1.0% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $3.9K | 150,000 | 1.0% |
| Epizyme Inc(EPZMEUR) | COM | 29428V104 | $3.5K | 113,188 | 0.9% |
| Colgate-Palmolive Co(CL) | COM | 194162103 | $3.3K | 47,799 | 0.8% |
| AutoNation Inc(AN)A | COM | 05329W102 | $3.1K | 52,600 | 0.8% |
| Broadcom Corp | CL A | 111320107 | $2.9K | 79,120 | 0.7% |
| Caesarstone Sdot-Yam Ltd(CSTE) | ORD SHS | M20598104 | $2.9K | 59,600 | 0.7% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $2.7K | 110,000 | 0.7% |
| Tetraphase Pharmaceuticals Inc | COM | 88165N105 | $2.7K | 198,000 | 0.7% |
| Google Inc | CL C | 38259P706 | $2.6K | 4,540 | 0.6% |
| Ampio Pharmaceuticals Inc | COM | 03209T109 | $2.6K | 312,000 | 0.6% |
| Receptos Inc | COM | 756207106 | $2.6K | 60,000 | 0.6% |
| MacroGenics Inc(MGNX) | COM | 556099109 | $2.4K | 111,000 | 0.6% |
| Celladon Corp | COM | 15117E107 | $2.4K | 150,000 | 0.6% |
| Oncothyreon Inc | COM | 682324108 | $2.4K | 738,336 | 0.6% |
| priceline.com Inc | COM NEW | 741503403 | $2.3K | 1,932 | 0.6% |
| Vanda Pharmaceuticals Inc(VNDA) | COM | 921659108 | $2.3K | 140,000 | 0.6% |
| Google Inc | CL A | 38259P508 | $2.2K | 3,784 | 0.5% |
| Actinium Pharmaceuticals Inc(ATNMEUR) | COM | 00507W107 | $2.2K | 300,000 | 0.5% |
| Akebia Therapeutics Inc(AKBA)A | COM | 00972D105 | $2.0K | 72,500 | 0.5% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $2.0K | 550,000 | 0.5% |